Genus PLC (GNS)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,986.00p

Buy

2,000.00p

arrow-down-2.00p (-0.10%)

Genus PLC focusses on the healthcare sector. It specializes in providing genetic products intended for animals, which allow farmers to produce an enhanced quality of milk products.
Prices updated at 05 Jun 2025, 19:12 BST
| Prices minimum 15 mins delay
|
Prices in GBX
FTSE All-Share
arrow-up0.08%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Iain George Thomas Ferguson CBE
CEO
Mr. Jorgen Kokke
Most recent earnings
30 Jun 2024
Fiscal year end
30 Jun 2024
Employees
3,573
Head office
Matrix House
Basingstoke
United Kingdom
RG21 4DZ
mobile
+44 1256347100
letter
charlesr@buchanan.uk.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Lesley Mary Samuel Knox OBE
Non-Executive Director, Senior Independent Director; Workforce Engagement Director
-----
Mr. Iain George Thomas Ferguson CBE
Non-Executive Director, Chairman
-----
Mr. Daniel William David Hartley
Group General Counsel & Company Secretary
-----
Ms. Alison Jane Henriksen
Executive Director, Chief Financial Officer
-----
Mr. Jorgen Kokke
Executive Director, Chief Executive Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Wellington Management Company LLP2,353,2461.86571-319451-31 May 20253.58
Capital Research and Management Company2,229,2030.472274083-31 May 20253.39
Jupiter Unit Trust Managers Ltd2,224,0097.43461--31 May 20253.39
European Opportunities Trust2,224,0097.43461--31 May 20253.39
Royal London Asset Management Ltd2,014,5317.69612-110000-31 May 20253.07

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
28 Feb 2025Exercise of OptionMr. Jorgen Kokke--103,0250.16Nil Cost
28 Feb 2025Sale of OptionMr. Jorgen Kokke1730.51345,53183,0580.13-
16 Sep 2024Sale of OptionMr. Jorgen Kokke1956.97330,25852,6290.08As advised by the company
16 Sep 2024Exercise of OptionMr. Jorgen Kokke--60,2780.09As advised by the company
16 Sep 2024Sale of OptionMr. Jorgen Kokke1956.0042,75858,0920.09As advised by the company
16 Sep 2024Exercise of OptionMr. Jorgen Kokke--69,5050.11As advised by the company
06 Sep 2024PurchaseMs. Lesley Mary Samuel Knox OBE1732.7748,5184,8000.01-
05 Sep 2024PurchaseMr. Iain George Thomas Ferguson CBE1763.6361,72713,5000.02-
05 Sep 2024PurchaseMr. Iain George Thomas Ferguson CBE1801.0063,03517,0000.03-
05 Sep 2024PurchaseMr. Iain George Thomas Ferguson CBE1800.0054,00020,0000.03-
05 Sep 2024PurchaseMr. Jorgen Kokke23.16242,03610,4500.02-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.